Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction

被引:44
作者
Tai, CT
Chiang, CE
Lee, SH
Chen, YJ
Yu, WC
Feng, AN
Ding, YA
Chang, MS
Chen, SA
机构
[1] Natl Yang Ming Univ, Sch Med, Vet Gen Hosp, Dept Med,Div Cardiol, Taipei 112, Taiwan
[2] Shin Kong Mem Hosp, Taipei, Taiwan
关键词
atrial fibrillation; atrial flutter; antiarrhythmic drugs;
D O I
10.1111/j.1540-8167.1999.tb00293.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiarrhythmic Drug-Related Atrial Flutter. Introduction: Antiarrhythmic drugs have been reported to promote the conversion of atrial fibrillation to atrial flutter in patients with paroxysmal atrial fibrillation, However, information about the electrophysiologic mechanism and response to radiofrequency ablation of these drug-induced atrial flutters is limited. Furthermore, the determinants of the development of persistent atrial flutter in patients treated for atrial fibrillation with antiarrhythmic drugs are still unknown. Methods and Results: Among the 136 patients treated for atrial fibrillation with amiodarone (n = 96) or propafenone (n = 40), 15 (11%, mean age 65.5 +/- 12.3 years) were identified to have subsequent development of persistent atrial flutter based on surface ECG characteristics during antiarrhythmic drug treatment. The mean interval between the beginning of drug treatment and the onset of atrial flutter was 5.0 +/- 5.5 months. Intracardiac mapping and entrainment studies revealed that 11 patients had counterclockwise typical atrial flutter, and 4 had clockwise typical atrial flutter, All 15 patients underwent successful ablation with creation of complete bidirectional isthmus conduction block. After a mean follow-up of 12.3 +/- 4.2 months, 14 (93%) of 15 patients who underwent successful ablation and continued taking antiarrhythmic drugs have remained in sinus rhythm. Univariate analysis of clinical variables demonstrated that only atrial enlargement was significantly related to the occurrence of persistent atrial flutter. Conclusion: In patients with atrial fibrillation, persistent typical atrial flutter might occur during antiarrhythmic drug treatment, and atrial enlargement was a risk factor for the development of such an arrhythmia. Radiofrequency ablation and continuation of pharmacologic therapy offered a safe and effective means of achieving and maintaining sinus rhythm.
引用
收藏
页码:1180 / 1187
页数:8
相关论文
共 22 条
[1]  
Boyden Penelope A., 1996, P137
[2]   CIBENZOLINE TRANSFORMS RANDOM REENTRY INTO ORDERED REENTRY IN THE ATRIA [J].
BRUGADA, J ;
GURSOY, S ;
BRUGADA, P ;
ATIE, J ;
GUIRAUDON, G ;
ANDRIES, E .
EUROPEAN HEART JOURNAL, 1993, 14 (02) :267-272
[3]   POLYMORPHIC VENTRICULAR-TACHYCARDIA INDUCED BY PROGRAMMED STIMULATION - RESPONSE TO PROCAINAMIDE [J].
BUXTON, AE ;
JOSEPHSON, ME ;
MARCHLINSKI, FE ;
MILLER, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (01) :90-98
[4]   Radiofrequency catheter ablation of common atrial flutter: Comparison of electrophysiologically guided focal ablation technique and linear ablation technique [J].
Chen, SA ;
Chiang, CE ;
Wu, TJ ;
Tai, CT ;
Lee, SH ;
Cheng, CC ;
Chiou, CW ;
Ueng, KC ;
Wen, ZC ;
Chang, MS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (04) :860-868
[5]   ATRIAL FLUTTER DURING QUINIDINE THERAPY OF ATRIAL FIBRILLATION [J].
CHENG, TO .
AMERICAN HEART JOURNAL, 1956, 52 (02) :273-289
[6]   THE SURGICAL-TREATMENT OF ATRIAL-FIBRILLATION .2. INTRAOPERATIVE ELECTROPHYSIOLOGIC MAPPING AND DESCRIPTION OF THE ELECTROPHYSIOLOGIC BASIS OF ATRIAL-FLUTTER AND ATRIAL-FIBRILLATION [J].
COX, JL ;
CANAVAN, TE ;
SCHUESSLER, RB ;
CAIN, ME ;
LINDSAY, BD ;
STONE, C ;
SMITH, PK ;
CORR, PB ;
BOINEAU, JP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 101 (03) :406-426
[7]   POSSIBLE ATRIAL PROARRHYTHMIC EFFECTS OF CLASS-1C ANTIARRHYTHMIC DRUGS [J].
FELD, GK ;
CHEN, PS ;
NICOD, P ;
FLECK, RP ;
MEYER, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (03) :378-383
[8]   Auricular fibrillation [J].
Garrey, WE .
PHYSIOLOGICAL REVIEWS, 1924, 4 (02) :215-250
[9]   Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation [J].
Huang, DT ;
Monahan, KM ;
Zimetbaum, P ;
Papageorgiou, P ;
Epstein, LM ;
Josephson, ME .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1998, 9 (05) :462-469
[10]   The results of atrial flutter ablation in patients with and without a history of atrial fibrillation [J].
Movsowitz, C ;
Callans, DJ ;
Schwartzman, D ;
Gottlieb, C ;
Marchlinski, FE .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (01) :93-&